Clinical Trial Update: Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,

View source ↗

Summary

This clinical trial update outlines a study evaluating a liquid biopsy approach to simultaneously detect ESR-1 and gBRCA mutations in HR+/HER2- metastatic breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer, Metastatic | Status: RECRUITING